Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Hypoxia in Malignant Gliomas Using EF5

NCT00430079 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT00430079
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00430079 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Hypoxia in Malignant Gliomas Using EF5
Lead sponsor
National Cancer Institute (NCI)
Phase
Not applicable
Overall status
Terminated
Start date
July 31, 2001
Completion date
Not reported
Enrollment
48 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adult anaplastic astrocytoma, adult anaplastic ependymoma, adult anaplastic oligodendroglioma, adult diffuse astrocytoma, adult ependymoma, adult giant cell glioblastoma, adult glioblastoma, adult gliosarcoma, adult mixed glioma, adult myxopapillary ependymoma, adult oligodendroglioma, adult pilocytic astrocytoma, adult pineal gland astrocytoma, adult subependymoma